David Pernock
Overview
David Pernock received an average of $3M in total compensation, including $566K in salary, at Eagle Pharmaceuticals from 2017 to 2021. David Pernock also received an average of $1M at Fibrocell Science from 2010 to 2016.
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
Eagle PharmaceuticalsFormer President and Chief Operating Officer
Eagle PharmaceuticalsPresident and Chief Operating Officer
Eagle PharmaceuticalsPresident and Chief Operating Officer
Eagle PharmaceuticalsPresident and Chief Operating Officer
Eagle PharmaceuticalsPresident and Chief Commercial Officer
Fibrocell ScienceFormer Chairman of the Board and Chief Executive Officer
Fibrocell ScienceFormer Chairman of the Board and Chief Executive Officer
Fibrocell ScienceChairman of the Board and Chief Executive Officer
Fibrocell ScienceChairman of the Board and Chief Executive Officer
Fibrocell ScienceChairman of the Board and Chief Executive Officer
Source: SEC filings on June 15, 2022, April 30, 2021, April 29, 2020, April 30, 2019, April 30, 2018, April 27, 2017, April 29, 2016, April 30, 2015, May 31, 2013, and August 6, 2012.
Related executives
We found 24 more executives who work or worked at Eagle Pharmaceuticals and Fibrocell Science.
Scott Tarriff
Eagle Pharmaceuticals
Chief Executive Officer
Michael Moran
Eagle Pharmaceuticals
Chief Commercial Officer
Brian Cahill
Eagle Pharmaceuticals
Chief Financial Officer
Judith Ng-Cashin
Eagle Pharmaceuticals
Chief Medical Officer
Pete Meyers
Eagle Pharmaceuticals
Chief Financial Officer
Adrian Hepner
Eagle Pharmaceuticals
Chief Medical Officer
Steven Krill
Eagle Pharmaceuticals
Chief Scientific Officer
John Maslowski
Fibrocell Science
Chief Executive Officer
News
Eagle Pharmaceuticals CEO Scott Tarriff's 2021 pay falls 32% to $6.5M
June 15, 2022
Eagle Pharmaceuticals CEO Scott Tarriff's 2020 pay rises 20% to $9.5M
April 30, 2021
Eagle Pharmaceuticals CEO Scott Tarriff's 2019 pay falls 30% to $7.9M
April 29, 2020
Eagle Pharmaceuticals CEO Scott Tarriff's 2018 pay jumps 41% to $11M
April 30, 2019